Proactive Investors
02 Jun 2026, 08:41 UTC · 2h ago
hVIVO win with Decoy Therapeutics signals shift towards broader contract research market, says broker
Search tags
Proactive Investors
02 Jun 2026, 08:41 UTC · 2h ago
Search tags
Story key points
3 claims · impact-rated
S&U PLC reported first-quarter trading ahead of budget and prior year, with Advantage Finance transactions increasing 63% year-on-year. — Strong organic growth and beating budget typically drive immediate positive price action for small-cap stocks.
+0.60hVIVO PLC has signed a consultancy contract with Decoy Therapeutics to support the development of Multi-Antiviral candidates. — While the financial terms are modest, it signals a strategic expansion of hVIVO's client base from big pharma to smaller biotechs.
+0.30S&U PLC expressed confidence in achieving double-digit growth for the current year. — Positive forward guidance supports a bullish outlook for the company's valuation.
+0.20Ticker attribution
Model heads
Continue reading
6 related stories
Reported Q1 trading ahead of budget and prior year, with significant growth in its motor finance arm.
Secured a new consultancy contract that demonstrates strategic expansion into a wider client base beyond big pharma.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
3 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
Invezz
2h ago
